CytoDyn (CYDY) EBT Margin (2021 - 2022)
CytoDyn's EBT Margin was -247414.71% in fiscal Q4 2022 (quarter ended May 31, 2022).
Powered by 
Analysis
CytoDyn (CYDY) EBT Margin (2021 - 2022) Analysis & Trends
For FY2022 (ended May 31, 2022), EBT Margin at CytoDyn came in at -70273.33%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | -4.34% |
| 10 | CytoDyn | 345.42 Mn | 296.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2022 | -247,414.71% |
| Nov 30, 2021 | -17,812.00% |
| Aug 31, 2021 | -110,578.05% |
API Access
CytoDyn EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();